Structure of chk1 10-pt. mutant complex with macrocyclic lrrk2 inhibitor compound 1 ((11r)-8-chloro-3,11-dimethyl-2-(oxan-4-yl)-2,4,10,11,12,13-hexahydro-9,5-(azeno)pyrazolo[3,4-b][1,4,6,10]oxatriazacyclotridecine) Deposition Author(s): Palte, R.L. , Yu, E.C. , Zhou, H.
Date: 2026-01-21 Method: X-RAY DIFFRACTION Resolution: 2.03 Å Organism(s): Homo Sapiens Sequences Data: 10HY_A
Structure of chk1 10-pt. mutant complex with macrocyclic lrrk2 inhibitor compound 7 ((10as,13as)-3-cyclobutyl-1-methyl-8-(trifluoromethyl)-3,4,10a,11,13a,14-hexahydro-10h,13h-9,5-(azeno)furo[3,4-k]pyrazolo[4,3-b][1,4,6,10]oxatriazacyclotridecine) Deposition Author(s): Palte, R.L. , Yu, E.C. , Zhou, H.
Date: 2026-01-21 Method: X-RAY DIFFRACTION Resolution: 1.666 Å Organism(s): Homo Sapiens Sequences Data: 10HZ_A
Structure of chk1 10-pt. mutant complex with macrocyclic lrrk2 inhibitor compound 12 ((10as,13as)-3-cyclopropyl-1-methyl-8-(trifluoromethyl)-3,4,10a,11,13a,14-hexahydro-10h,13h-9,5-(azeno)furo[3,4-k]pyrazolo[4,3-b][1,4,6,10]oxatriazacyclotridecine) Deposition Author(s): Palte, R.L. , Yu, E.C. , Zhou, H.
Date: 2026-01-21 Method: X-RAY DIFFRACTION Resolution: 1.739 Å Organism(s): Homo Sapiens Sequences Data: 10IA_A